http, --www.math.pitt.edu-bard-xpp-xpp.htm --www.math.pitt.edu-bard-xpp-xpp.html. (). http:--www.math.pitt.edu-bard-xpp-xpp.html.
. (2004). Safinamide: FCE 26743, NW 1015, PNU 151774, PNU 151774E. Drugs in R&D. 5 [PubMed]
Abbott LF, Farhi E, Gutmann S. (1991). The path integral for dendritic trees. Biological cybernetics. 66 [PubMed]
Aiken CB. (2007). Pramipexole in psychiatry: a systematic review of the literature. The Journal of clinical psychiatry. 68 [PubMed]
Alt A et al. (2006). In vitro and in vivo studies in rats with LY293558 suggest AMPA/kainate receptor blockade as a novel potential mechanism for the therapeutic treatment of anxiety disorders. Psychopharmacology. 185 [PubMed]
Amano T et al. (2004). Antiepileptic effects of single and repeated oral administrations of S-312-d, a novel calcium channel antagonist, on tonic convulsions in spontaneously epileptic rats. Journal of pharmacological sciences. 95 [PubMed]
Amico C, Marchetti C, Nobile M, Usai C. (1995). Pharmacological types of calcium channels and their modulation by baclofen in cerebellar granules. The Journal of neuroscience : the official journal of the Society for Neuroscience. 15 [PubMed]
Anis N et al. (1990). Structure-activity relationships of philanthotoxin analogs and polyamines on N-methyl-D-aspartate and nicotinic acetylcholine receptors. The Journal of pharmacology and experimental therapeutics. 254 [PubMed]
Annoura H et al. (2000). Discovery of (2S)-1-(4-amino-2,3,5- trimethylphenoxy)-3-[4-[4-(4- fluorobenzyl)phenyl]-1-piperazinyl]-2-propanol dimethanesulfonate (SUN N8075): a dual Na(+) and Ca(2+) channel blocker with antioxidant activity. Journal of medicinal chemistry. 43 [PubMed]
Aradi I, Erdi P. (2006). Computational neuropharmacology: dynamical approaches in drug discovery. Trends in pharmacological sciences. 27 [PubMed]
Ascoli GA. (2006). Mobilizing the base of neuroscience data: the case of neuronal morphologies. Nature reviews. Neuroscience. 7 [PubMed]
Ascoli GA, Donohue DE, Halavi M. (2007). NeuroMorpho.Org: a central resource for neuronal morphologies. The Journal of neuroscience : the official journal of the Society for Neuroscience. 27 [PubMed]
Baert L et al. (2008). Development of an implantable infusion pump for sustained anti-HIV drug administration. International journal of pharmaceutics. 355 [PubMed]
Baf MH, Subhash MN, Lakshmana KM, Rao BS. (1994). Sodium valproate induced alterations in monoamine levels in different regions of the rat brain. Neurochemistry international. 24 [PubMed]
Bai O, Zhang H, Li XM. (2004). Antipsychotic drugs clozapine and olanzapine upregulate bcl-2 mRNA and protein in rat frontal cortex and hippocampus. Brain research. 1010 [PubMed]
Bauer J, Schwalen S. (2000). [Topiramate (Topamax). Pharmacological characteristics and current use in epilepsy treatment] Nervenarzt. 71
Bayes M, Rabasseda X, Prous JR. (2007). Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 29
Bell DC et al. (2001). Biophysical properties, pharmacology, and modulation of human, neuronal L-type (alpha(1D), Ca(V)1.3) voltage-dependent calcium currents. Journal of neurophysiology. 85 [PubMed]
Berger ML, Rebernik P. (1999). Zinc and ifenprodil allosterically inhibit two separate polyamine-sensitive sites at N-methyl-D-aspartate receptor complex. The Journal of pharmacology and experimental therapeutics. 289 [PubMed]
Bezprozvanny I, Bezprozvannaya S, Ehrlich BE. (1994). Caffeine-induced inhibition of inositol(1,4,5)-trisphosphate-gated calcium channels from cerebellum. Molecular biology of the cell. 5 [PubMed]
Bhalla US, Iyengar R. (1999). Emergent properties of networks of biological signaling pathways. Science (New York, N.Y.). 283 [PubMed]
Black KJ et al. (2002). A possible substrate for dopamine-related changes in mood and behavior: prefrontal and limbic effects of a D3-preferring dopamine agonist. Proceedings of the National Academy of Sciences of the United States of America. 99 [PubMed]
Blier P et al. (2007). Which antidepressants have demonstrated superior efficacy? A review of the evidence. Int Clin Psychopharmacol. 22
Bogan RK. (2008). Ropinirole treatment for restless legs syndrome. Expert opinion on pharmacotherapy. 9 [PubMed]
Boulenger JP, Marangos PJ. (1989). Caffeine withdrawal affects central adenosine receptors but not benzodiazepine receptors. J Neural Transm Gen Sect. 78
Bourasset F, Bernard K, Muñoz C, Genissel P, Scherrmann JM. (2005). Neuropharmacokinetics of a new alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) modulator, S18986 [(S)-2,3-dihydro-[3,4]cyclopentano-1,2,4-benzothiadiazine-1,1-dioxide], in the rat. Drug metabolism and disposition: the biological fate of chemicals. 33 [PubMed]
Bower JM, Beeman D. (1995). The Book of GENESIS: Exploring Realistic Neural Models with the GEneral NEural SImulation System..
Brier TJ et al. (2003). Contrasting actions of philanthotoxin-343 and philanthotoxin-(12) on human muscle nicotinic acetylcholine receptors. Molecular pharmacology. 64 [PubMed]
Buckner SA et al. (2000). Pharmacological and molecular analysis of ATP-sensitive K(+) channels in the pig and human detrusor. European journal of pharmacology. 400 [PubMed]
Bush G et al. (2008). Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task. Archives of general psychiatry. 65 [PubMed]
Béracochéa D, Philippin JN, Meunier S, Morain P, Bernard K. (2007). Improvement of episodic contextual memory by S 18986 in middle-aged mice: comparison with donepezil. Psychopharmacology. 193 [PubMed]
Calfa G, Bussolino D, Molina VA. (2007). Involvement of the lateral septum and the ventral Hippocampus in the emotional sequelae induced by social defeat: role of glucocorticoid receptors. Behavioural brain research. 181 [PubMed]
Callaway JK et al. (2004). Sodium channel blocking activity of AM-36 and sipatrigine (BW619C89): in vitro and in vivo evidence. Neuropharmacology. 47 [PubMed]
Callaway JK, Knight MJ, Watkins DJ, Beart PM, Jarrott B. (1999). Delayed treatment with AM-36, a novel neuroprotective agent, reduces neuronal damage after endothelin-1-induced middle cerebral artery occlusion in conscious rats. Stroke. 30 [PubMed]
Camerino DC, Tricarico D, Desaphy JF. (2007). Ion channel pharmacology. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 4 [PubMed]
Carter AJ et al. (2000). Potent blockade of sodium channels and protection of brain tissue from ischemia by BIII 890 CL. Proceedings of the National Academy of Sciences of the United States of America. 97 [PubMed]
Castelli L, Magistretti J. (2006). High-voltage-activated Ca2+ currents show similar patterns of expression in stellate and pyramidal cells from rat entorhinal cortex layer II. Brain research. 1090 [PubMed]
Chapman DE, Keefe KA, Wilcox KS. (2003). Evidence for functionally distinct synaptic NMDA receptors in ventromedial versus dorsolateral striatum. Journal of neurophysiology. 89 [PubMed]
Chazot PL. (2001). Safinamide (Newron Pharmaceuticals). Current opinion in investigational drugs (London, England : 2000). 2 [PubMed]
Cheney JA et al. (2001). The maxi-K channel opener BMS-204352 attenuates regional cerebral edema and neurologic motor impairment after experimental brain injury. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. 21 [PubMed]
Chorvat RJ, Zaczek R, Brown BS. (1998). Ion channel modulators that enhance acetylcholine release: potential therapies for Alzheimer's disease. Expert opinion on investigational drugs. 7 [PubMed]
Chung JM, Huguenard JR, Prince DA. (1993). Transient enhancement of low-threshold calcium current in thalamic relay neurons after corticectomy. Journal of neurophysiology. 70 [PubMed]
Cohen SP, Dragovich A. (2007). Intrathecal analgesia. Anesthesiology clinics. 25 [PubMed]
Contreras M, Ceric F, Torrealba F. (2007). Inactivation of the interoceptive insula disrupts drug craving and malaise induced by lithium. Science (New York, N.Y.). 318 [PubMed]
Coppola G et al. (2002). Topiramate as add-on drug in severe myoclonic epilepsy in infancy: an Italian multicenter open trial. Epilepsy research. 49 [PubMed]
Crasto CJ et al. (2007). SenseLab: new developments in disseminating neuroscience information. Briefings in bioinformatics. 8 [PubMed]
Cui G, Bernier BE, Harnett MT, Morikawa H. (2007). Differential regulation of action potential- and metabotropic glutamate receptor-induced Ca2+ signals by inositol 1,4,5-trisphosphate in dopaminergic neurons. The Journal of neuroscience : the official journal of the Society for Neuroscience. 27 [PubMed]
Cunningham MO, Woodhall GL, Thompson SE, Dooley DJ, Jones RS. (2004). Dual effects of gabapentin and pregabalin on glutamate release at rat entorhinal synapses in vitro. The European journal of neuroscience. 20 [PubMed]
D'Angelo E et al. (2001). Theta-frequency bursting and resonance in cerebellar granule cells: experimental evidence and modeling of a slow k+-dependent mechanism. The Journal of neuroscience : the official journal of the Society for Neuroscience. 21 [PubMed]
Dan Y, Poo MM. (2006). Spike timing-dependent plasticity: from synapse to perception. Physiological reviews. 86 [PubMed]
Danysz W, Parsons CG. (2002). Neuroprotective potential of ionotropic glutamate receptor antagonists. Neurotoxicity research. 4 [PubMed]
Dave JR et al. (2001). RS-100642-198, a novel sodium channel blocker, provides differential neuroprotection against hypoxia/hypoglycemia, veratridine or glutamate-mediated neurotoxicity in primary cultures of rat cerebellar neurons. Neurotoxicity research. 3 [PubMed]
Dave JR et al. (2003). Down regulation of sodium channel Na(v)1.1 expression by veratridine and its reversal by a novel sodium channel blocker, RS100642, in primary neuronal cultures. Neurotoxicity research. 5 [PubMed]
Dekker LV et al. (2005). Analysis of human Nav1.8 expressed in SH-SY5Y neuroblastoma cells. European journal of pharmacology. 528 [PubMed]
Denes L, Szilágyi G, Gál A, Nagy Z. (2006). Talampanel a non-competitive AMPA-antagonist attenuates caspase-3 dependent apoptosis in mouse brain after transient focal cerebral ischemia. Brain research bulletin. 70 [PubMed]
Di Donato M et al. (1991). Acute hemodynamic effects of intravenous diperdipine, a new dihydropyridine derivative, in coronary heart disease. American heart journal. 121 [PubMed]
Di_donato M, Fantini F, Marchionni N. (1992). Cardiovasc Drug Rev. 10
Dodt HU et al. (2007). Ultramicroscopy: three-dimensional visualization of neuronal networks in the whole mouse brain. Nature methods. 4 [PubMed]
Du F, Li R, Huang Y, Li X, Le W. (2005). Dopamine D3 receptor-preferring agonists induce neurotrophic effects on mesencephalic dopamine neurons. The European journal of neuroscience. 22 [PubMed]
Easton N, Marshall F, Fone K, Marsden C. (2007). Atomoxetine produces changes in cortico-basal thalamic loop circuits: assessed by phMRI BOLD contrast. Neuropharmacology. 52 [PubMed]
Eghbali M, Curmi JP, Birnir B, Gage PW. (1997). Hippocampal GABA(A) channel conductance increased by diazepam. Nature. 388 [PubMed]
Egorov AV, Heinemann U, Müller W. (2002). Differential excitability and voltage-dependent Ca2+ signalling in two types of medial entorhinal cortex layer V neurons. The European journal of neuroscience. 16 [PubMed]
Eigyo M et al. (1994). Pharmacological studies on a new dihydrothienopyridine calcium antagonist, S-312-d. 5th communication: anticonvulsant effects in mice. Japanese journal of pharmacology. 65 [PubMed]
Elefsinioti AL, Bagos PG, Spyropoulos IC, Hamodrakas SJ. (2004). A database for G proteins and their interaction with GPCRs. BMC bioinformatics. 5 [PubMed]
Fernandez HH, Chen JJ. (2007). Monoamine oxidase-B inhibition in the treatment of Parkinson's disease. Pharmacotherapy. 27 [PubMed]
Fischer F, Herrling P, Matthisson M. (2004). List of drugs in development for neurodegenerative diseases. Neurodegener Dis. 1
Foster JD, Cervinski MA, Gorentla BK, Vaughan RA. (2006). Regulation of the dopamine transporter by phosphorylation. Handb Exp Pharmacol. 64
Fujiki M, Kobayashi H, Uchida S, Inoue R, Ishii K. (2005). Neuroprotective effect of donepezil, a nicotinic acetylcholine-receptor activator, on cerebral infarction in rats. Brain research. 1043 [PubMed]
Gardner D, Shepherd GM. (2004). A gateway to the future of neuroinformatics. Neuroinformatics. 2 [PubMed]
Gaster LM, King FD. (1997). Serotonin 5-HT3 and 5-HT4 receptor antagonists. Medicinal research reviews. 17 [PubMed]
Gauthier S et al. (1986). Transmitter-replacement therapy in Alzheimer's disease using intracerebroventricular infusions of receptor agonists. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. 13 [PubMed]
Gazulla J, Tintore MA. (2007). The P/Q-type voltage-dependent calcium channel as pharmacological target in spinocerebellar ataxia type 6: gabapentin and pregabalin may be of therapeutic benefit. Med Hypotheses. 68
Gefvert O et al. (2001). D(2) and 5HT(2A) receptor occupancy of different doses of quetiapine in schizophrenia: a PET study. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. 11 [PubMed]
Gernert M, Fedrowitz M, Wlaz P, Löscher W. (2004). Subregional changes in discharge rate, pattern, and drug sensitivity of putative GABAergic nigral neurons in the kindling model of epilepsy. The European journal of neuroscience. 20 [PubMed]
Giardina WJ, Williams M. (2001). Adrogolide HCl (ABT-431; DAS-431), a prodrug of the dopamine D1 receptor agonist, A-86929: preclinical pharmacology and clinical data. CNS drug reviews. 7 [PubMed]
Giovannini F, Sher E, Webster R, Boot J, Lang B. (2002). Calcium channel subtypes contributing to acetylcholine release from normal, 4-aminopyridine-treated and myasthenic syndrome auto-antibodies-affected neuromuscular junctions. British journal of pharmacology. 136 [PubMed]
Goldstein J, Silberstein SD, Saper JR, Ryan RE, Lipton RB. (2006). Acetaminophen, aspirin, and caffeine in combination versus ibuprofen for acute migraine: results from a multicenter, double-blind, randomized, parallel-group, single-dose, placebo-controlled study. Headache. 46 [PubMed]
Gopalakrishnan M et al. (1999). Characterization of the ATP-sensitive potassium channels (KATP) expressed in guinea pig bladder smooth muscle cells. The Journal of pharmacology and experimental therapeutics. 289 [PubMed]
Gorelick DA, Gardner EL, Xi ZX. (2004). Agents in development for the management of cocaine abuse. Drugs. 64 [PubMed]
Gourion D, Perrin E, Quintin P. (2006). [Fluoxetine: an update of its use in major depressive disorder in adults] Encephale. 30
Green W, Patil P, Marsden CA, Bennett GW, Wigmore PM. (2006). Treatment with olanzapine increases cell proliferation in the subventricular zone and prefrontal cortex. Brain research. 1070 [PubMed]
Gribkoff VK et al. (2001). Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels. Nature medicine. 7 [PubMed]
Grunder G et al. (2007). W J Nucl Med. 48
Gören MZ, Onat F. (2007). Ethosuximide: from bench to bedside. CNS drug reviews. 13 [PubMed]
Hall ED, Andrus PK, Oostveen JA, Althaus JS, VonVoigtlander PF. (1996). Neuroprotective effects of the dopamine D2/D3 agonist pramipexole against postischemic or methamphetamine-induced degeneration of nigrostriatal neurons. Brain research. 742 [PubMed]
Happe S, Sauter C, Klösch G, Saletu B, Zeitlhofer J. (2003). Gabapentin versus ropinirole in the treatment of idiopathic restless legs syndrome. Neuropsychobiology. 48 [PubMed]
Hasselmo ME. (1995). Neuromodulation and cortical function: modeling the physiological basis of behavior. Behavioural brain research. 67 [PubMed]
Heidbreder C. (2005). Novel pharmacotherapeutic targets for the management of drug addiction. European journal of pharmacology. 526 [PubMed]
Hewawasam P et al. (2002). Synthesis and structure-activity relationships of 3-aryloxindoles: a new class of calcium-dependent, large conductance potassium (maxi-K) channel openers with neuroprotective properties. Journal of medicinal chemistry. 45 [PubMed]
Hewawasam P et al. (2002). The synthesis and characterization of BMS-204352 (MaxiPost) and related 3-fluorooxindoles as openers of maxi-K potassium channels. Bioorganic & medicinal chemistry letters. 12 [PubMed]
Hines ML, Carnevale NT. (1997). The NEURON simulation environment. Neural computation. 9 [PubMed]
Howes JF, Bell C. (2007). Talampanel. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 4 [PubMed]
Hoyte L, Barber PA, Buchan AM, Hill MD. (2004). The rise and fall of NMDA antagonists for ischemic stroke. Current molecular medicine. 4 [PubMed]
Hughes ZA et al. (2005). Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone. European journal of pharmacology. 510 [PubMed]
Huguenard JR. (1996). Low-threshold calcium currents in central nervous system neurons. Annual review of physiology. 58 [PubMed]
Hunnicutt EJ, Davis JN, Chisholm JC. (1994). A new glibenclamide-insensitive neuroselective hyperpolarizing agent. European journal of pharmacology. 261 [PubMed]
Iivanainen M. (1998). Phenytoin: effective but insidious therapy for epilepsy in people with intellectual disability. Journal of intellectual disability research : JIDR. 42 Suppl 1 [PubMed]
Iwama T, Nagai Y, Tamura N, Harada S, Nagaoka A. (1991). A novel glutamate agonist, TAN-950 A, isolated from streptomycetes. European journal of pharmacology. 197 [PubMed]
Jakus R et al. (2004). Effect of two noncompetitive AMPA receptor antagonists GYKI 52466 and GYKI 53405 on vigilance, behavior and spike-wave discharges in a genetic rat model of absence epilepsy. Brain research. 1008 [PubMed]
Jansen JF et al. (2006). Functional MRI reveals declined prefrontal cortex activation in patients with epilepsy on topiramate therapy. Epilepsy & behavior : E&B. 9 [PubMed]
Jensen BS. (2002). BMS-204352: a potassium channel opener developed for the treatment of stroke. CNS drug reviews. 8 [PubMed]
Jones N, O'Neill MJ, Tricklebank M, Libri V, Williams SC. (2005). Examining the neural targets of the AMPA receptor potentiator LY404187 in the rat brain using pharmacological magnetic resonance imaging. Psychopharmacology. 180 [PubMed]
Kasim S et al. (2006). The role of dopamine receptors in the neurobehavioral syndrome provoked by activation of L-type calcium channels in rodents. Developmental neuroscience. 28 [PubMed]
Katz I, Kim J, Gale K, Kondratyev A. (2007). Effects of lamotrigine alone and in combination with MK-801, phenobarbital, or phenytoin on cell death in the neonatal rat brain. The Journal of pharmacology and experimental therapeutics. 322 [PubMed]
Kendall TJ, Minchin MC. (1982). The effects of anaesthetics on the uptake and release of amino acid neurotransmitters in thalamic slices. British journal of pharmacology. 75 [PubMed]
Kiss T, Erdi P. (2006). From electric patterns to drugs: perspectives of computational neuroscience in drug design. Bio Systems. 86 [PubMed]
Kondashevskaya MV, Kudrin VS, Malikova LA, Klodt PM, Makarova OV. (2006). Effect of single and repeated administration of high-molecular-weight heparin in low doses on brain content of neurotransmitters in Wistar rats. Bulletin of experimental biology and medicine. 141 [PubMed]
Korngreen A, Kaiser KM, Zilberter Y. (2005). Subthreshold inactivation of voltage-gated K+ channels modulates action potentials in neocortical bitufted interneurones from rats. The Journal of physiology. 562 [PubMed]
Korsgaard MP et al. (2005). Anxiolytic effects of Maxipost (BMS-204352) and retigabine via activation of neuronal Kv7 channels. The Journal of pharmacology and experimental therapeutics. 314 [PubMed]
Kotaleski JH, Lester D, Blackwell KT. (2002). Subcellular interactions between parallel fibre and climbing fibre signals in Purkinje cells predict sensitivity of classical conditioning to interstimulus interval. Integrative physiological and behavioral science : the official journal of the Pavlovian Society. 37 [PubMed]
Kroppenstedt SN, Schneider GH, Thomale UW, Unterberg AW. (1998). Neuroprotective properties of aptiganel HCL (Cerestat) following controlled cortical impact injury. Acta neurochirurgica. Supplement. 71 [PubMed]
Kwon MO, Fischer F, Matthisson M, Herrling P. (2004). List of drugs in development for neurodegenerative diseases. Update June 2004. Neuro-degenerative diseases. 1 [PubMed]
Kwon MO, Herrling P. (2006). List of drugs in development for neurodegenerative diseases. Update June 2006. Neuro-degenerative diseases. 3 [PubMed]
Lam HY et al. (2007). AlzPharm: integration of neurodegeneration data using RDF. BMC bioinformatics. 8 Suppl 3 [PubMed]
Lazareno S, Popham A, Birdsall NJ. (2003). Progress toward a high-affinity allosteric enhancer at muscarinic M1 receptors. Journal of molecular neuroscience : MN. 20 [PubMed]
Lea PM, Faden AI. (2006). Metabotropic glutamate receptor subtype 5 antagonists MPEP and MTEP. CNS drug reviews. 12 [PubMed]
Lee CR, Tepper JM. (2007). A calcium-activated nonselective cation conductance underlies the plateau potential in rat substantia nigra GABAergic neurons. The Journal of neuroscience : the official journal of the Society for Neuroscience. 27 [PubMed]
Lee CY, Fu WM, Chen CC, Su MJ, Liou HH. (2008). Lamotrigine inhibits postsynaptic AMPA receptor and glutamate release in the dentate gyrus. Epilepsia. 49 [PubMed]
Lee HJ, Pogatzki-Zahn EM, Brennan TJ. (2006). The effect of the AMPA/kainate receptor antagonist LY293558 in a rat model of postoperative pain. The journal of pain. 7 [PubMed]
Levin ED, McClernon FJ, Rezvani AH. (2006). Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology. 184 [PubMed]
Li Z et al. (2005). ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens. Psychopharmacology. 183 [PubMed]
Lindskog M, Kim M, Wikström MA, Blackwell KT, Kotaleski JH. (2006). Transient calcium and dopamine increase PKA activity and DARPP-32 phosphorylation. PLoS computational biology. 2 [PubMed]
Lockhart BP et al. (2007). S18986: a positive modulator of AMPA-receptors enhances (S)-AMPA-mediated BDNF mRNA and protein expression in rat primary cortical neuronal cultures. European journal of pharmacology. 561 [PubMed]
Maguire GA. (2002). Comprehensive understanding of schizophrenia and its treatment. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 59 [PubMed]
Malphrus AD, Wilfong AA. (2007). Use of the newer antiepileptic drugs in pediatric epilepsies. Current treatment options in neurology. 9 [PubMed]
Mamo D et al. (2007). Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study. The American journal of psychiatry. 164 [PubMed]
Markram H. (2006). The blue brain project. Nature reviews. Neuroscience. 7 [PubMed]
Marzatico F, Dagani F, Curti D, Benzi G. (1987). Phenobarbital and 6-aminonicotinamide effect on cerebral enzymatic activities related to energy metabolism in different rat brain areas. Neurochemical research. 12 [PubMed]
McBurney RN et al. (1992). New CNS-specific calcium antagonists. Journal of neurotrauma. 9 Suppl 2 [PubMed]
McLeod MC, Sundram S, Dean B. (2008). Treatment with haloperidol and diazepam alters GABA(A) receptor density in the rat brain. Progress in neuro-psychopharmacology & biological psychiatry. 32 [PubMed]
Menon M et al. (2007). Temporal difference modeling of the blood-oxygen level dependent response during aversive conditioning in humans: effects of dopaminergic modulation. Biological psychiatry. 62 [PubMed]
Meshkibaf MH, Subhash MN, Lakshmana KM, Rao BS. (1995). Effect of chronic administration of phenytoin on regional monoamine levels in rat brain. Neurochemical research. 20 [PubMed]
Meyer JH et al. (2002). Bupropion occupancy of the dopamine transporter is low during clinical treatment. Psychopharmacology. 163 [PubMed]
Meythaler J. (2002). BIII-890-CL. Boehringer Ingelheim. Current opinion in investigational drugs (London, England : 2000). 3 [PubMed]
Micheva KD, Taylor CP, Smith SJ. (2006). Pregabalin reduces the release of synaptic vesicles from cultured hippocampal neurons. Molecular pharmacology. 70 [PubMed]
Migliore M, Cannia C, Canavier CC. (2008). A modeling study suggesting a possible pharmacological target to mitigate the effects of ethanol on reward-related dopaminergic signaling. Journal of neurophysiology. 99 [PubMed]
Migliore M, Messineo L, Ferrante M. (2004). Dendritic Ih selectively blocks temporal summation of unsynchronized distal inputs in CA1 pyramidal neurons. Journal of computational neuroscience. 16 [PubMed]
Migliore M et al. (2003). ModelDB: making models publicly accessible to support computational neuroscience. Neuroinformatics. 1 [PubMed]
Migliore M, Shepherd GM. (2002). Emerging rules for the distributions of active dendritic conductances. Nature reviews. Neuroscience. 3 [PubMed]
Mikami A, Masuoka T, Yasuda M, Yamamoto Y, Kamei C. (2007). Participation of cholinergic system in memory deficits induced by blockade of hippocampal mGlu(1) receptors. European journal of pharmacology. 575 [PubMed]
Moller A et al. (1996). Bioorg Med Chem Lett. 6
Mora TC, Suarez-Kurtz G. (2005). Effects of NS1608, a BK(Ca) channel agonist, on the contractility of guinea-pig urinary bladder in vitro. British journal of pharmacology. 144 [PubMed]
Muir KW, Grosset DG, Lees KR. (1997). Effects of prolonged infusions of the NMDA antagonist aptiganel hydrochloride (CNS 1102) in normal volunteers. Clin Neuropharmacol. 20
Mutani R, Cantello R, Gianelli M, Civardi C. (1995). Antiepileptic drugs and mechanisms of epileptogenesis. A review. Italian journal of neurological sciences. 16 [PubMed]
Møller A et al. (1995). Pharmacological profile and anti-ischemic properties of the Ca(2+)-channel blocker NS-638. Neurological research. 17 [PubMed]
Nasledov GA, Skvortsova IV, Skorobovichuk NF. (2007). [Effect of inositol triphosphate receptor blocker heparin on contractions in the Lampetra fluviatilis muscle] Zh Evol Biokhim Fiziol. 37
Nicolazzo JA et al. (2008). Pharmacokinetics and brain uptake of AM-36, a novel neuroprotective agent, following intravenous administration to rats. The Journal of pharmacy and pharmacology. 60 [PubMed]
Nordquist RE, Steckler T, Wettstein JG, Mackie C, Spooren W. (2008). Metabotropic glutamate receptor modulation, translational methods, and biomarkers: relationships with anxiety. Psychopharmacology. 199 [PubMed]
O'Leary OF et al. (2007). Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test. Psychopharmacology. 192 [PubMed]
O'Neill MJ et al. (1997). Effects of Ca2+ and Na+ channel inhibitors in vitro and in global cerebral ischaemia in vivo. European journal of pharmacology. 332 [PubMed]
Obrietan K, van den Pol AN. (1999). GABAB receptor-mediated regulation of glutamate-activated calcium transients in hypothalamic and cortical neuron development. Journal of neurophysiology. 82 [PubMed]
Olesen SP, Møller A, Mordvintcev PI, Busse R, Mülsch A. (1997). Regional measurements of NO formed in vivo during brain ischemia. Acta neurologica Scandinavica. 95 [PubMed]
Paloyelis Y, Mehta MA, Kuntsi J, Asherson P. (2007). Functional MRI in ADHD: a systematic literature review. Expert review of neurotherapeutics. 7 [PubMed]
Parihar AS et al. (2003). Functional analysis of large conductance Ca2(+)-activated K(+) channels: ion flux studies by atomic absorption spectrometry. Assay and drug development technologies. 1 [PubMed]
Pattij T, Vanderschuren LJ. (2008). The neuropharmacology of impulsive behaviour. Trends in pharmacological sciences. 29 [PubMed]
Pepeu G et al. (2004). S 18986, a positive modulator of AMPA receptors with cognition-enhancing properties, increases ACh release in the hippocampus of young and aged rat. Neurosci Lett. 361
Petroff OA, Hyder F, Rothman DL, Mattson RH. (2001). Topiramate rapidly raises brain GABA in epilepsy patients. Epilepsia. 42 [PubMed]
Poolos NP, Migliore M, Johnston D. (2002). Pharmacological upregulation of h-channels reduces the excitability of pyramidal neuron dendrites. Nature neuroscience. 5 [PubMed]
Popescu BO et al. (2006). Dantrolene protects neurons against kainic acid induced apoptosis in vitro and in vivo. J Cell Mol Med. 6
Posner EB, Mohamed K, Marson AG. (2005). A systematic review of treatment of typical absence seizures in children and adolescents with ethosuximide, sodium valproate or lamotrigine. Seizure. 14
Quiroz JA, Gould TD, Manji HK. (2004). Molecular effects of lithium. Molecular interventions. 4 [PubMed]
Ramaprasad S, Ripp E, Pi J, Lyon M. (2005). Pharmacokinetics of lithium in rat brain regions by spectroscopic imaging. Magnetic resonance imaging. 23 [PubMed]
Ramirez AD, Wong SK, Menniti FS. (2003). Pramipexole inhibits MPTP toxicity in mice by dopamine D3 receptor dependent and independent mechanisms. European journal of pharmacology. 475 [PubMed]
Reimann W, Schneider F. (1998). Induction of 5-hydroxytryptamine release by tramadol, fenfluramine and reserpine. European journal of pharmacology. 349 [PubMed]
Reneman L, De Bruin K, Lavalaye J, Gunning WB, Booij J. (2001). Addition of a 5-HT receptor agonist to methylphenidate potentiates the reduction of [123I]FP-CIT binding to dopamine transporters in rat frontal cortex and hippocampus. Synapse (New York, N.Y.). 39 [PubMed]
Reymann K, Pohle W, Müller-Welde P, Ott T. (1983). Dopaminergic innervation of the hippocampus: evidence for midbrain raphe neurons as the site of origin. Biomedica biochimica acta. 42 [PubMed]
Reynolds GP et al. (1995). 5-Hydroxytryptamine (5-HT)4 receptors in post mortem human brain tissue: distribution, pharmacology and effects of neurodegenerative diseases. British journal of pharmacology. 114 [PubMed]
Reynolds MF, Sisk EC, Rasgon NL. (2007). Valproate and neuroendocrine changes in relation to women treated for epilepsy and bipolar disorder: a review. Current medicinal chemistry. 14 [PubMed]
Rogawski MA. (2006). Diverse mechanisms of antiepileptic drugs in the development pipeline. Epilepsy research. 69 [PubMed]
Rose GM, Ong VS, Woodruff-Pak DS. (2007). Efficacy of MEM 1003, a novel calcium channel blocker, in delay and trace eyeblink conditioning in older rabbits. Neurobiology of aging. 28 [PubMed]
Rose JE et al. (2007). Regional brain activity correlates of nicotine dependence. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 32 [PubMed]
Rosenberg H, Davis M, James D, Pollock N, Stowell K. (2007). Malignant hyperthermia. Orphanet journal of rare diseases. 2 [PubMed]
Sandrini G, Perrotta A, Nappi G. (2006). Eletriptan: a review and new perspectives. Expert review of neurotherapeutics. 6 [PubMed]
Sansone V, Tawil R. (2007). Management and treatment of Andersen-Tawil syndrome (ATS). Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 4 [PubMed]
Saraga F, Wu CP, Zhang L, Skinner FK. (2003). Active dendrites and spike propagation in multi-compartment models of oriens-lacunosum/moleculare hippocampal interneurons. The Journal of physiology. 552 [PubMed]
Schiffer WK et al. (2006). Therapeutic doses of amphetamine or methylphenidate differentially increase synaptic and extracellular dopamine. Synapse (New York, N.Y.). 59 [PubMed]
Schoepp DD, Wright RA, Levine LR, Gaydos B, Potter WZ. (2003). LY354740, an mGlu2/3 receptor agonist as a novel approach to treat anxiety/stress. Stress (Amsterdam, Netherlands). 6 [PubMed]
Schrøder RL et al. (2001). KCNQ4 channel activation by BMS-204352 and retigabine. Neuropharmacology. 40 [PubMed]
Schwarz AJ, Gozzi A, Reese T, Bifone A. (2007). In vivo mapping of functional connectivity in neurotransmitter systems using pharmacological MRI. NeuroImage. 34 [PubMed]
Schwarz AJ, Gozzi A, Reese T, Heidbreder CA, Bifone A. (2007). Pharmacological modulation of functional connectivity: the correlation structure underlying the phMRI response to d-amphetamine modified by selective dopamine D3 receptor antagonist SB277011A. Magnetic resonance imaging. 25 [PubMed]
Schüle C. (2007). Neuroendocrinological mechanisms of actions of antidepressant drugs. Journal of neuroendocrinology. 19 [PubMed]
Shan H, Messi ML, Zheng Z, Wang ZM, Delbono O. (2003). Preservation of motor neuron Ca2+ channel sensitivity to insulin-like growth factor-1 in brain motor cortex from senescent rat. The Journal of physiology. 553 [PubMed]
Shapiro RE. (2007). Caffeine and headaches. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 28 Suppl 2 [PubMed]
Shieh CC et al. (2007). A-272651, a nonpeptidic blocker of large-conductance Ca2+-activated K+ channels, modulates bladder smooth muscle contractility and neuronal action potentials. British journal of pharmacology. 151 [PubMed]
Shimazawa M et al. (2007). Prevention of in vitro and in vivo acute ischemic neuronal damage by (2S)-1-(4-amino-2,3,5-trimethylphenoxy)-3-{4-[4-(4-fluorobenzyl) phenyl]-1-piperazinyl}-2-propanol dimethanesulfonate (SUN N8075), a novel neuroprotective agent with antioxidant properties. Neuroscience. 149
Siddiqui A, Niazi A, Shaharyar S, Wilson CA. (2007). The 5HT(7) receptor subtype is involved in the regulation of female sexual behaviour in the rat. Pharmacology, biochemistry, and behavior. 87 [PubMed]
Silberstein SD et al. (2007). Efficacy of eletriptan in migraine-related functional impairment: functional and work productivity outcomes. Headache. 47 [PubMed]
Simonyi A, Schachtman TR, Christoffersen GR. (2007). The role of metabotropic glutamate receptor 5 in learning and memory processes. Drug News Perspect. 18
Skolnick P, Popik P, Janowsky A, Beer B, Lippa AS. (2003). Antidepressant-like actions of DOV 21,947: a "triple" reuptake inhibitor. European journal of pharmacology. 461 [PubMed]
Skolnick P, Popik P, Janowsky A, Beer B, Lippa AS. (2003). "Broad spectrum" antidepressants: is more better for the treatment of depression? Life sciences. 73 [PubMed]
Slassi A et al. (2005). Recent advances in non-competitive mGlu5 receptor antagonists and their potential therapeutic applications. Current topics in medicinal chemistry. 5 [PubMed]
Slattery DA et al. (2005). Comparison of alterations in c-fos and Egr-1 (zif268) expression throughout the rat brain following acute administration of different classes of antidepressant compounds. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 30 [PubMed]
Smith CP et al. (1996). Serotonergic activity of HP 184: does spontaneous release have a role? Neurochemical research. 21 [PubMed]
Solai LK, Mulsant BH, Pollock BG. (2001). Selective serotonin reuptake inhibitors for late-life depression: a comparative review. Drugs & aging. 18 [PubMed]
Soldovieri MV et al. (2007). Atypical gating of M-type potassium channels conferred by mutations in uncharged residues in the S4 region of KCNQ2 causing benign familial neonatal convulsions. The Journal of neuroscience : the official journal of the Society for Neuroscience. 27 [PubMed]
Spinelli S et al. (2005). Effects of the mGluR2/3 agonist LY354740 on computerized tasks of attention and working memory in marmoset monkeys. Psychopharmacology. 179 [PubMed]
Striessnig J et al. (2006). Role of voltage-gated L-type Ca2+ channel isoforms for brain function. Biochemical Society transactions. 34 [PubMed]
Strupp M, Zwergal A, Brandt T. (2007). Episodic ataxia type 2. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 4 [PubMed]
Sun L, Lin SS. (2000). The anticonvulsant SGB-017 (ADCI) blocks voltage-gated sodium channels in rat and human neurons: comparison with carbamazepine. Epilepsia. 41 [PubMed]
Szarfman A, Tonning JM, Levine JG, Doraiswamy PM. (2006). Atypical antipsychotics and pituitary tumors: a pharmacovigilance study. Pharmacotherapy. 26 [PubMed]
Szepetowski P, Genton P, Audic-Gerard F. (2003). [GEFS + syndrome: phenotypic variations from the newborn to the adult in a large French pedigree] Rev Neurol (Paris). 159
Tang L, Kongsamut S. (1996). Frequency-dependent inhibition of neurotransmitter release by besipirdine and HP 184. European journal of pharmacology. 300 [PubMed]
Tarnawa I, Bölcskei H, Kocsis P. (2007). Blockers of voltage-gated sodium channels for the treatment of central nervous system diseases. Recent patents on CNS drug discovery. 2 [PubMed]
Teoh H, Fowler LJ, Bowery NG. (1995). Effect of lamotrigine on the electrically-evoked release of endogenous amino acids from slices of dorsal horn of the rat spinal cord. Neuropharmacology. 34 [PubMed]
Uruno K, O'Connor MJ, Masukawa LM. (1995). Effects of bicuculline and baclofen on paired-pulse depression in the dentate gyrus of epileptic patients. Brain research. 695 [PubMed]
Vann RE, Rosecrans JA, James JR, Philibin SD, Robinson SE. (2006). Neurochemical and behavioral effects of bupropion and mecamylamine in the presence of nicotine. Brain research. 1117 [PubMed]
Vargas ML, Abella C, Hernandez J. (2001). Diazepam increases the hypothalamic-pituitary-adrenocortical (HPA) axis activity by a cyclic AMP-dependent mechanism. British journal of pharmacology. 133 [PubMed]
Verheij MM, Cools AR. (2007). Differential contribution of storage pools to the extracellular amount of accumbal dopamine in high and low responders to novelty: effects of reserpine. Journal of neurochemistry. 100 [PubMed]
Villringer A et al. (2006). Dysfunction of ventral striatal reward prediction in schizophrenia. Neuroimage. 29
Winston JS, Strange BA, O'Doherty J, Dolan RJ. (2002). Automatic and intentional brain responses during evaluation of trustworthiness of faces. Nature neuroscience. 5 [PubMed]
Wong EY, Herbert J. (2005). Roles of mineralocorticoid and glucocorticoid receptors in the regulation of progenitor proliferation in the adult hippocampus. The European journal of neuroscience. 22 [PubMed]
Yagami T et al. (2004). Protective effects of a selective L-type voltage-sensitive calcium channel blocker, S-312-d, on neuronal cell death. Biochemical pharmacology. 67 [PubMed]
Yasui M, Kawasaki K. (1994). Vulnerability of CA1 neurons in SHRSP hippocampal slices to ischemia, and its protection by Ca2+ channel blockers. Brain research. 642 [PubMed]
Youdim MB, Buccafusco JJ. (2005). CNS Targets for multi-functional drugs in the treatment of Alzheimer's and Parkinson's diseases. Journal of neural transmission (Vienna, Austria : 1996). 112 [PubMed]
Young BL et al. (2007). Chiral purity assay for Flindokalner using tandem mass spectrometry: method development, validation, and benchmarking. Journal of pharmaceutical and biomedical analysis. 43 [PubMed]
Zaczek R et al. (1998). Two new potent neurotransmitter release enhancers, 10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone and 10,10-bis(2-fluoro-4-pyridinylmethyl)-9(10H)-anthracenone: comparison to linopirdine. The Journal of pharmacology and experimental therapeutics. 285 [PubMed]
Zarate CA et al. (2004). Pramipexole for bipolar II depression: a placebo-controlled proof of concept study. Biological psychiatry. 56 [PubMed]
Zhang D et al. (2005). Metabolism, pharmacokinetics, and protein covalent binding of radiolabeled MaxiPost (BMS-204352) in humans. Drug metabolism and disposition: the biological fate of chemicals. 33 [PubMed]
Zhang L, Andou Y, Masuda S, Mitani A, Kataoka K. (1993). Dantrolene protects against ischemic, delayed neuronal death in gerbil brain. Neuroscience letters. 158 [PubMed]
Zhang L, Liu Y, Chen X. (2005). Carbachol induces burst firing of dopamine cells in the ventral tegmental area by promoting calcium entry through L-type channels in the rat. The Journal of physiology. 568 [PubMed]
Zhang L, Zhang Y, Wennberg R. (1998). Multiple actions of methohexital on hippocampal CA1 and cortical neurons of rat brain slices. The Journal of pharmacology and experimental therapeutics. 286 [PubMed]
Zhang W et al. (2007). SynDB: a Synapse protein DataBase based on synapse ontology. Nucleic acids research. 35 [PubMed]
Zhu MY, Wang WP, Bissette G. (2006). Neuroprotective effects of agmatine against cell damage caused by glucocorticoids in cultured rat hippocampal neurons. Neuroscience. 141 [PubMed]
de Paulis T. (2007). Drug evaluation: Vilazodone--a combined SSRI and 5-HT1A partial agonist for the treatment of depression. IDrugs : the investigational drugs journal. 10 [PubMed]
htt http, . (). http:--www.caregiver.org-caregiver-jsp-content_node.jsp?nodeid=438.
htt http, --senselab.med.yale.edu-BrainPhar --senselab.med.yale.edu-BrainPharm. (). http:--senselab.med.yale.edu-BrainPharm.
htt http, --www.drugs.com --www.drugs.com-. (). http:--www.drugs.com-.
htt http, --www.fabrekramer.com-TGBA01AD.htm --www.fabrekramer.com-TGBA01AD.html. (). http:--www.fabrekramer.com-TGBA01AD.html.
htt http, --www.memorypharma.com-news-PR_061207.htm --www.memorypharma.com-news-PR_061207.html. (). http:--www.memorypharma.com-news-PR_061207.html.
htt http, --www.ncbi.nlm.nih.gov-sites-entre --www.ncbi.nlm.nih.gov-sites-entrez. (). http:--www.ncbi.nlm.nih.gov-sites-entrez.
htt http, --www.rxlist.com-script-main-hp.as --www.rxlist.com-script-main-hp.asp. (). http:--www.rxlist.com-script-main-hp.asp.
htt http, --www.technologypartners.com-assets-Saegis.pd --www.technologypartners.com-assets-Saegis.pdf. (). http:--www.technologypartners.com-assets-Saegis.pdf.
Cavarretta F, Carnevale NT, Tegolo D, Migliore M. (2014). Effects of low frequency electric fields on synaptic integration in hippocampal CA1 pyramidal neurons: implications for power line emissions. Frontiers in cellular neuroscience. 8 [PubMed]
Culmone V, Migliore M. (2012). Progressive effect of beta amyloid peptides accumulation on CA1 pyramidal neurons: a model study suggesting possible treatments. Frontiers in computational neuroscience. 6 [PubMed]
Ferrante M, Ascoli GA. (2015). Distinct and synergistic feedforward inhibition of pyramidal cells by basket and bistratified interneurons. Frontiers in cellular neuroscience. 9 [PubMed]
Ferrante M, Migliore M, Ascoli GA. (2013). Functional impact of dendritic branch-point morphology. The Journal of neuroscience : the official journal of the Society for Neuroscience. 33 [PubMed]
Le Franc Y, Le Masson G. (2010). Multiple firing patterns in deep dorsal horn neurons of the spinal cord: computational analysis of mechanisms and functional implications. Journal of neurophysiology. 104 [PubMed]
Makadia HK et al. (2015). Multiscale model of dynamic neuromodulation integrating neuropeptide-induced signaling pathway activity with membrane electrophysiology. Biophysical journal. 108 [PubMed]
McDougal RA, Hines ML, Lytton WW. (2013). Reaction-diffusion in the NEURON simulator. Frontiers in neuroinformatics. 7 [PubMed]
Parasuram H et al. (2016). Computational Modeling of Single Neuron Extracellular Electric Potentials and Network Local Field Potentials using LFPsim. Frontiers in computational neuroscience. 10 [PubMed]
Parekh R, Ascoli GA. (2013). Neuronal morphology goes digital: a research hub for cellular and system neuroscience. Neuron. 77 [PubMed]